PACS Group, Inc. (PACS) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

69/ 100

GoAI Score

Buy

Valuation

87

Deep Value

Sentiment

61

Bullish

Risk

33

Moderate Risk

Momentum

70

Gaining

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.

Industry: Medical - Care Facilities
Sector: Healthcare
Headquarters: US
CEO: Jason Murray
Listed since: Apr 11, 2024
Employees: 47,455

Market position

Day range

Current $43.45

$42.57$43.88

52-week range

Current $43.45

$10.31$49.49

Open: $42.89
Previous close: $43.19
Volume: 257.4K; 0.3× average
Average volume: 856.43K; Average daily volume
Market cap: 6.88B USD
Beta: -0.08; Market reference 1
50-day average: $43.7798; -0.75% below average
200-day average: $39.092; +11.15% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 9.27B USD
P/E (TTM): 25.56×
P/B (TTM): 6.19×
P/S (TTM): 1.24×
EV / EBITDA: 25.36×
Earnings yield: 3.19%
Free cash flow yield: 4.98%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 19.68%
Operating margin: 7.39%
Net margin: 4.85%
Return on equity: 20.23%
Return on assets: 3.43%
Return on invested capital: 4.37%

Financial health

Debt / equity: 2.93×
Current ratio: 1.07×
Altman Z-score: 2.22
Piotroski F-score: 7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

5.29B USD+29.32%

Operating income

309.6M USD+151.55%

Net income

191.54M USD+243.51%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.29B USD	4.09B USD	3.11B USD	2.42B USD	1.17B USD
Cost of goods sold	4.13B USD	3.3B USD	2.66B USD	2.02B USD	979.22M USD
Gross profit	1.16B USD	792.64M USD	447.07M USD	400.68M USD	187.35M USD
Selling, general, and administrative	415.07M USD	343.81M USD	213.66M USD	149.01M USD	96.83M USD
Operating expenses	849.64M USD	669.57M USD	239.3M USD	171.32M USD	103.99M USD
Interest expense	28.36M USD	44.34M USD	49.92M USD	25.54M USD	5.28M USD
Depreciation and amortization	55.66M USD	40.81M USD	25.63M USD	22.31M USD	7.15M USD
Operating income	309.6M USD	123.07M USD	207.77M USD	229.36M USD	83.36M USD
Net income	191.54M USD	55.76M USD	112.87M USD	150.5M USD	47.95M USD

Company facts updated Oct 8, 2026.

Earnings

EPS beat rate: 50%; 5 beats, 5 misses, 0 met estimates
Average EPS surprise: -6.43%; 10 comparable reports
Latest EPS result: 0.63; Estimate 0.54 · Beat by 17.32%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Latest fiscal-year EPS: 1.22; FY2025 · +221.05% year over year
Latest fiscal-year revenue: 5.29B USD; FY2025 · +29.32% year over year
Next fiscal-year EPS consensus: 2.44; FY2026 · 3 analysts
Next fiscal-year revenue consensus: 5.84B USD; FY2026 · 4 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$56.67

30.43% upside

Past 12 months12-month forecastHigh $62.00Average $56.67Low $48.00

Rating distribution

8 ratings

Strong buy00%

Buy8100%

Hold00%

Sell00%

Strong sell00%

Recent analyst actions

8 institutions

MacquariemaintainOutperformJan 6, 2025

CitigroupmaintainBuyAug 13, 2024

PACS news

defenseworld.netOct 8, 2026

PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 717 Shares of Stock

PACS Group, Inc. (NYSE: PACS - Get Free Report) CEO Jason Murray sold 717 shares of PACS Group stock in a transaction dated Wednesday, October 7th. The shares were sold at an average price of $42.48, for a total value of…

Read source

businesswire.comOct 5, 2026

Omega to Transition Operations of 32 Facilities in Florida to PACS Group

HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that it transitioned 32 skilled nursing facilities in Florida from an…

Read source

businesswire.comSep 30, 2026

Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS”) is proud to announce that 17 of its post-acute communities have been named by Newsweek Magazine to its list of Best Nursing Homes for 2027. Those…

Read source

gurufocus.comSep 26, 2026

Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 25, 2026Shareholders are encouraged to contact the firm t

Read source

prnewswire.comSep 25, 2026

Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket…

Read source

defenseworld.netSep 24, 2026

Critical Contrast: InnovAge (NASDAQ:INNV) and PACS Group (NYSE:PACS)

PACS Group (NYSE: PACS - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their…

Read source